Get the Stockscreener App
0.3574
2.55%
0.0089
Pharmacyte Biotech Inc Stock (PMCB) Forecast
The Pharmacyte Biotech Inc (PMCB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.3544, representing a -0.84% decrease from the current price of $0.3574. The highest analyst price target is $0.6715, and the lowest is $0.0373.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PMCB Price Target
Average 0.4221
(+18.10% Upside)
Is Pharmacyte Biotech Inc (PMCB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.07 | Neutral |
| STOCH(9,6) | 14.94 | Buy |
| STOCHRSI(14) | 24.21 | Neutral |
| MACD(12,26) | -0.0308 | Sell |
| ADX(14) | 24.31 | Neutral |
| William %R | -83.76 | Buy |
| CCI(14) | -110.42 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3847
Sell
|
0.3805
Sell
|
| MA20 |
0.4098
Sell
|
0.4034
Sell
|
| MA50 |
0.4669
Sell
|
0.4666
Sell
|
| MA100 |
0.5848
Sell
|
0.5478
Sell
|
| MA200 |
0.6712
Sell
|
0.6591
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PMCB could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on PMCB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.07 indicates that PMCB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.94 indicates that PMCB is oversold. This indicates that PMCB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.21 indicates that PMCB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.31 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -110.42 indicates that PMCB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term PMCB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pharmacyte Biotech Inc financial reports and earnings history, Pharmacyte Biotech Inc (PMCB) stock could reach $0.8141 by 2030, $2.1485 by 2040 and $8.5387 by 2050. See the projected annual prices until 2050 of the Pharmacyte Biotech Inc stock below:
- Pharmacyte Biotech Inc (PMCB) is expected to reach an average price of $0.6117 in 2035, with a high prediction of $0.6222 and a low estimate of $0.6917. This indicates an $71.16% rise from the last recorded price of $0.3574.
- Pharmacyte Biotech Inc (PMCB) stock is projected to chart a bullish course in 2040, with an average price target of $2.1674, representing an $506.42% surge from its current level. The forecast ranges from a conservative $2.1974 to a sky-high $2.1485.
- Our analysts predict Pharmacyte Biotech Inc (PMCB) to jump 1,210% by 2045, soaring from $4.7793 to an average price of $4.6828, potentially reaching $4.701. While $4.7793 is the low estimate, the potential upside is significant.
- Pharmacyte Biotech Inc (PMCB) stock is expected to climb by 2050, reaching an average of $8.4981, a $2,278% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.5387 and $8.5681, respectively, highlighting the market's uncertainty.
Pharmacyte Biotech Inc Stock (PMCB) Year by Year Forecast
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2026
The predicted value for Pharmacyte Biotech Inc (PMCB) in 2026 is set at an average of $0.5255. Estimates vary from a peak of $1.05 to a trough of $0.00101, indicating an +47.04% surge from the present price of $0.3574.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.2397 | $0.0373 | $0.6715 | -32.92% |
| December, 2026 | $0.368 | $0.00101 | $0.378 | +2.96% |
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pharmacyte Biotech Inc (PMCB) is $0.5248, with a high forecast of $1.0458 and a low forecast of $0.00381. This indicates an +46.84% increase from the last price of $0.3574.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2438 | $0.0399 | $0.5221 | -31.78% |
| February, 2027 | $0.1356 | $0.1897 | $0.0556 | -62.06% |
| March, 2027 | $0.0603 | $0.1373 | $0.1915 | -83.13% |
| April, 2027 | $0.0679 | $0.00381 | $0.2438 | -81.00% |
| May, 2027 | $0.0532 | $0.0268 | $0.3291 | -85.11% |
| June, 2027 | $0.1614 | $0.0144 | $0.1664 | -54.83% |
| July, 2027 | $0.0697 | $0.0215 | $0.2885 | -80.51% |
| August, 2027 | $0.3449 | $0.0267 | $0.4349 | -3.49% |
| September, 2027 | $0.7932 | $0.2691 | $0.8432 | +121.93% |
| October, 2027 | $0.6414 | $0.4673 | $0.8202 | +79.46% |
| November, 2027 | $0.7467 | $0.3455 | $0.8467 | +108.92% |
| December, 2027 | $0.9349 | $0.7281 | $1.0458 | +161.58% |
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2028
In 2028, Pharmacyte Biotech Inc (PMCB) is projected to reach an average price of $1.0992, with a high projection of $1.5219 and a low estimate of $0.6766. This indicates an +207.56% rise from the last price of $0.3574.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0202 | $0.9061 | $1.1731 | +185.45% |
| February, 2028 | $1.0384 | $0.7872 | $1.0643 | +190.54% |
| March, 2028 | $1.0766 | $0.9655 | $1.1675 | +201.24% |
| April, 2028 | $1.1699 | $0.9807 | $1.1949 | +227.32% |
| May, 2028 | $1.1001 | $1.0301 | $1.206 | +207.82% |
| June, 2028 | $1.1784 | $0.9872 | $1.2413 | +229.71% |
| July, 2028 | $1.3536 | $0.9566 | $1.3836 | +278.75% |
| August, 2028 | $1.4519 | $1.3223 | $1.5219 | +306.23% |
| September, 2028 | $1.2101 | $1.106 | $1.4789 | +238.58% |
| October, 2028 | $0.9654 | $0.9654 | $1.2341 | +170.11% |
| November, 2028 | $0.8336 | $0.6766 | $1.0224 | +133.24% |
| December, 2028 | $0.7318 | $0.7018 | $1.0338 | +104.77% |
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2029
The 2029 price forecast for Pharmacyte Biotech Inc Stock (PMCB) is $0.7953 on average, with a high prediction of $1.2106 and a low estimate of $0.3801. This represents an +122.53% increase from the previous price of $0.3574.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5271 | $0.3801 | $0.7065 | +47.49% |
| February, 2029 | $0.5153 | $0.4412 | $0.7183 | +44.19% |
| March, 2029 | $0.7036 | $0.4024 | $0.8936 | +96.86% |
| April, 2029 | $0.7888 | $0.6418 | $0.8647 | +120.72% |
| May, 2029 | $0.7971 | $0.6859 | $0.8959 | +123.02% |
| June, 2029 | $0.6953 | $0.5962 | $0.8212 | +94.54% |
| July, 2029 | $1.0006 | $0.5608 | $1.2106 | +179.96% |
| August, 2029 | $0.7688 | $0.7218 | $1.1876 | +115.11% |
| September, 2029 | $0.787 | $0.707 | $0.9229 | +120.21% |
| October, 2029 | $0.6723 | $0.4611 | $1.1253 | +88.11% |
| November, 2029 | $0.7105 | $0.6794 | $0.9635 | +98.81% |
| December, 2029 | $0.6658 | $0.5788 | $0.8176 | +86.30% |
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2030
Pharmacyte Biotech Inc Stock (PMCB) is expected to reach an average price of $0.6922 in 2030, with a high forecast of $1.2934 and a low forecast of $0.091. This signifies an +93.68% surge from the last price of $0.3574.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.7141 | $0.1899 | $0.8141 | +99.79% |
| February, 2030 | $0.6123 | $0.3311 | $1.0111 | +71.31% |
| March, 2030 | $0.6805 | $0.5064 | $1.2934 | +90.40% |
| April, 2030 | $0.6159 | $0.4517 | $0.8317 | +72.32% |
| May, 2030 | $0.504 | $0.4428 | $0.7249 | +41.02% |
| June, 2030 | $0.6472 | $0.4481 | $0.7551 | +81.10% |
| July, 2030 | $0.7575 | $0.4405 | $0.8975 | +111.95% |
| August, 2030 | $0.6057 | $0.4887 | $0.8646 | +69.49% |
| September, 2030 | $0.251 | $0.091 | $0.6726 | -29.76% |
| October, 2030 | $0.1993 | $0.1493 | $0.4815 | -44.25% |
| November, 2030 | $0.1375 | $0.0964 | $0.2663 | -61.53% |
| December, 2030 | $0.2628 | $0.1245 | $0.3028 | -26.48% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):